The GLP is committed to full transparency. Download and review our Annual Report.

Gene therapy: Engineered ‘heart-healing virus’ trial starts

| | April 30, 2013

The following is an excerpt.

Patients in the UK have been enrolled into a trial to see if an engineered virus can be used to heal their damaged and struggling hearts.

The trial will use a virus to introduce genetic material into heart muscle to reverse the organ’s decline.

The British Heart Foundation said the idea had “great potential” but needed to be proven in clinical trials.

Read the full article here: Gene therapy: ‘Heart-healing virus’ trial starts

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend